Literature DB >> 16304632

An open letter to our readers on the use of antibodies.

Clifford B Saper.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16304632     DOI: 10.1002/cne.20839

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


× No keyword cloud information.
  83 in total

1.  Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples.

Authors:  Marie-Pierre Loit; Homa Adle-Biassette; Schahrazed Bouazza; Marie-Christine Mazeron; Philippe Manivet; Jacqueline Lehmann-Che; Natacha Teissier; Emmanuel Mandonnet; Jean-Michel Molina
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

2.  A new module for on-line manipulation and display of molecular information in the brain architecture management system.

Authors:  Mihail Bota; Larry W Swanson
Journal:  Neuroinformatics       Date:  2006

Review 3.  Localization and targeting of voltage-dependent ion channels in mammalian central neurons.

Authors:  Helene Vacher; Durga P Mohapatra; James S Trimmer
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

4.  Commercial antibodies: the good, bad, and really ugly.

Authors:  John R Couchman
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

Review 5.  Antibody validation.

Authors:  Jennifer Bordeaux; Allison Welsh; Seema Agarwal; Elizabeth Killiam; Maria Baquero; Jason Hanna; Valsamo Anagnostou; David Rimm
Journal:  Biotechniques       Date:  2010-03       Impact factor: 1.993

Review 6.  Synthesis, trafficking, and localization of muscarinic acetylcholine receptors.

Authors:  Neil M Nathanson
Journal:  Pharmacol Ther       Date:  2008-05-16       Impact factor: 12.310

7.  Comment from the Editor-in-Chief on correspondence in this issue on immuno-techniques.

Authors:  J C McGrath
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

8.  Formation of heteromeric Kv2 channels in mammalian brain neurons.

Authors:  Yoshitaka Kihira; Tracey O Hermanstyne; Hiroaki Misonou
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

9.  Generation and characterization of a single-chain anti-EphA2 antibody.

Authors:  Yehuda Goldgur; Petri Susi; Eveliina Karelehto; Hanna Sanmark; Urpo Lamminmäki; Elisa Oricchio; Hans-Guido Wendel; Dimitar B Nikolov; Juha P Himanen
Journal:  Growth Factors       Date:  2014-11-19       Impact factor: 2.511

10.  Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

Authors:  Julius Benicky; Roman Hafko; Enrique Sanchez-Lemus; Greti Aguilera; Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2012-07-28       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.